Article
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.
Nature communications - 27 Jul 2016
Jacoby Elad, Nguyen Sang M, Fountaine Thomas J, Welp Kathryn, Gryder Berkley, Qin Haiying, Yang Yinmeng, Chien Christopher D, Seif Alix E, Lei Haiyan, Song Young K, Khan Javed, Lee Daniel W, Mackall Crystal L, Gardner Rebecca A, Jensen Michael C, Shern Jack F, Fry Terry J
Abstract excerpt
Adoptive immunotherapy using chimeric antigen receptor (CAR) expressing T cells targeting the CD19 B lineage receptor has demonstrated marked success in relapsed pre-B-cell acute lymphoblastic leukaemia (ALL). Persisting CAR-T cells generate sustained pressure against CD19 that may drive unique mechanisms of resistance. Pre-B ALL originates from a committed pre-B cell or an earlier progenitor, with potential to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
